Semaglutide with B12: the claims, and what was measured

What this comes down to

• Our September 2026 search found no randomized-trial reports of semaglutide or tirzepatide with B12. The identical filter finds 23 trial-tagged reports of metformin with B12, so the filter can find drug-plus-vitamin trials.
• Eleven records mention a GLP-1 and a B12 term at all. Three of those mention nausea, and none of the three tests the combination.
• A randomized, double-blind, placebo-controlled crossover trial of a 1,000 microgram B12 injection in twenty singers with mild vocal fatigue found improvements after B12 and after placebo that were comparable to each other.
• Promotion by or on behalf of a compounder has to be truthful and non-misleading, and the FDA says it monitors it.

The nausea claim

Nausea in the first weeks is the reason usually given for the vitamin, and it is a claim about an anti-emetic effect. Anti-emetic effects are easy to test — the same filter that finds nothing for a GLP-1 with B12 finds 863 trial-tagged reports of ondansetron and nausea. That result does not establish that every study of the combination would be found. Whether the combination has been studied at all is the question the companion article answers; what we would add is that the three records mentioning a GLP-1, a B12 term and nausea together are a case report of neuropathy after semaglutide-associated gastrointestinal intolerance, a 2026 review of micronutrient risk on incretin drugs, and a pharmacology review about achieving glycemic control without nausea. None of them tests adding B12 to reduce nausea.

The zero, and a control chosen to be hard to pass. A PubMed search finds 0 results; the same search for metformin with B12 finds 23.

The energy claim, and the one trial shaped like it

B12 injections for tiredness are older than GLP-1s and have been tested on their own terms. The cleanest example is a randomized, double-blind, placebo-controlled crossover trial at an academic voice center: twenty adult singers without hoarseness but with mild vocal symptoms — reduced stamina, vocal fatigue, effort — each received an intramuscular injection of 1,000 micrograms of cyanocobalamin and, after a washout of at least four weeks, an injection of 0.9% saline^[1]. Anyone with known or suspected B12 deficiency was excluded, which is the design choice that makes it relevant here.

At the primary time point, 72 hours, the improvements after B12 and after placebo were comparable to each other. The median change on the primary measure was 1 point after B12 and 3 after placebo. People felt better after both.

How much has actually been asked. A PubMed search finds 9 results; the same search for ondansetron and nausea finds 863.

What the vitamin is approved to do

Cyanocobalamin injection is an old, approved product with a narrow indication: vitamin B12 deficiency caused by malabsorption. Nothing in that approval concerns nausea from another drug, and nothing in it concerns energy in people whose levels are normal. What a standalone B12 or lipotropic shot is is covered separately, and the answer does not change when the vitamin rides along with a GLP-1.

There is a real question underneath all of this, which is whether GLP-1 drugs cause B12 deficiency the way metformin can. That is exactly why the metformin control is the right one: the metformin-and-B12 literature exists because a genuine drug-induced deficiency was found and then studied 23 times. The equivalent literature for GLP-1s is a 2026 review describing micronutrient risk as a mechanism to monitor, not a measured deficiency with a dose response^[3]. A vitamin added preemptively to every vial is not a response to that.

What a seller is allowed to say

Compounded drugs are not approved, are not reviewed for safety, effectiveness or quality before they are sold, and a compounded drug is not a generic^[4]. Prescription drug promotion by or on behalf of a compounder still has to be truthful, non-misleading and accurate, and the agency says it monitors promotional material. Two claims to weigh against that standard when you see them:

• "B12 reduces the nausea." Our September 2026 search found no trial reports of the combination, and the three records that mention both and nausea test something else entirely.
• "The B12 gives you energy." Tested in the shape most likely to succeed — a real injection, in people with symptoms, against saline — and it came out comparable to placebo.
• "It is the same as the brand, with a bonus." The FDA lists a company claiming a compounded drug is the same as an approved one among its telehealth red flags, and the added ingredient is also what the copy rule turns on — the companion article works through that.

Then ask the only question with a number in it: what the same seller charges for the drug without the vitamin. Our calculator holds a membership fee and a medication price apart from each other, which is usually where the difference turns out to be hiding.

Questions people actually ask